SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000; 12: 240245.
  • 2
    Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003; 260: 502508.
  • 3
    Lisowska J, Zatonski W. Tumours of the larynx in Poland in comparison to other European countries. Otolaryngol Pol 1992; 46: 211216.
  • 4
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. Cancer J Clin 1997; 47: 527.
  • 5
    Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumour control in cervical lymph node metastases from head and neck cancer. Cancer 1992; 69: 12241234.
  • 6
    Schwartz JL. Biomarkers and molecular epidemiology and chemoprevention of oral arcinogenesis. Crit Rev Oral Biol Med 2000; 11: 92122.
  • 7
    Szyfter K, Szmeja Z, Szyfter W, Hemminki K, Banaszewski J, Jaskula-Sztul R, Louhelainen J. Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutat Res 1999; 445: 259274.
  • 8
    Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumours: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997; 57: 27652780.
  • 9
    Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, Grenman R, Carey TE. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 2000; 60: 33973403.
  • 10
    Ransom DT, Barnett TC, Bot J, de-Boer B, Metcalf C, Davidson JA, Turbett GR. Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer. Head Neck 1998; 20: 404410.
  • 11
    Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancer. Cancer Res 1993; 53: 57755779.
  • 12
    Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenic analysis of solid tumours. Science 1992; 258: 818821.
  • 13
    Speicher MR, Howe C, Crotty P, du-Manoir S, Costa J, Ward DC. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995; 55: 10101013.
  • 14
    Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF. Frequent novel DNA copy number increase in squamous cell head and neck tumours. Cancer Res 1995; 55: 30553059.
  • 15
    Stafford ND, Ashman JN, MacDonald AW, Ell SR, Monson JR, Greenman J. Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. Arch Otolaryngol Head Neck Surg 1999; 125: 13411348.
  • 16
    Bergamo NA, Rogatto SR, Poli-Frederico RC, Reis PP, Kowalski LP, Zielenska M, Squire JA. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 2000; 119: 4855.
  • 17
    Bockmühl U, Schlüns K, Küchler I, Petersen S, Petersen I. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 2000; 157: 369375.
  • 18
    Welkoborsky HJ, Bernauer HS, Riazimand HS, Jacob R, Mann WJ, Hinni ML. Patterns of chromosomal aberrations in metastasing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx. Ann Otol Rhinol Laryngol 2000; 109: 401410.
  • 19
    Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R, Schantz SP. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumour sites: construction of oncogenetic trees for tumour progression. Genes Chromosomes Cancer 2002; 34: 224233.
  • 20
    Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002; 33: 2935.
  • 21
    Gebhart E, Liehr T. Patterns of genomic imbalances in human solid tumours. Int J Oncol 2000; 16: 383399.
  • 22
    Helliwell TR. Molecular markers of metastasis in squamous carcinomas. J Pathol 2001; 194: 289293.
  • 23
    Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anticancer Res 1999; 19: 925931.
  • 24
    Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M. Cyclin-D1–gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 1997; 74: 576581.
  • 25
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumours. Laryngoscope 2002; 112: 472481.
  • 26
    Nimeus E, Baldetorp B, Bendahl PO, Rennstam K, Wennerberg J, Akervall J, Ferno M. Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Oral Oncol 2004; 40: 624629.
  • 27
    Barra S, Barzan L, Maione A, Cadelano A, Pin M, Franceschi S, Comoretto R. Blood transfusion and other prognostic variables in the survival of patients wit the cancer of the head and neck. Laryngoscope 1984; 104: 9598.
  • 28
    Juhász A, Bárdos H, Répássy G, Ádány R. Characteristic distribution patters of tenascin in laryngeal and hypopharyngeal cancers. Laryngoscope 2000; 110: 8492.
  • 29
    Balázs M, Ádám Zs, Treszl A, Bégány Á, Hunyadi J, Ádány R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001; 46: 222232.
  • 30
    Treszl A, Adany R, Rakosy Z, Kardos L, Begany A, Gilde K, Balazs M. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation. Cytometry 2004; 60: 3746.
  • 31
    Dhingra K, Sneige N, Pandita TK, Johnston DA, Lee JS, Emami K, Hortobagyi GN, Hittelman WN. Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. Cytometry 1994; 16: 100112.
  • 32
    CummingsCW, FredericksonJM, HackerLA, KrauseCJ, SchullerDE, RichardsonMA, editors. Otolaryngology—head and neck surgery. Volume 3. St. Louis: Mosby Year Book; 1998.
  • 33
    Juhász A, Bárdos H, Répássy G, Ádány R. Characteristic distribution patters of tenascin in laryngeal and hypopharyngeal cancers. Laryngoscope 2000; 110: 8492.
  • 34
    Bárdos H, Juhász A, Répássy G, Ádány R. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx. Thromb Haemost 1998; 80: 767772.
  • 35
    Répássy G, Forster-Horváth Cs, Juhász A, Ádány R, Tamássy A, Timár J. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 1998; 4: 1421.
  • 36
    Dammann R, Yang G, Pfeifer GP. Hypermethylation of the cpG island of Ras association domain family 1A(RASSF1A), a putative tumour suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001; 61: 31053109.
  • 37
    Schafer KA. The cell cycle: a review. Vet Pathol 1998; 35: 461478.
  • 38
    Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 2002; 20: 4552.
  • 39
    Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380389.
  • 40
    Monteiro E, Varzim G, Pires AM, Teixeira M, Lopes C. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumour localization and tobacco exposure. Cancer Detect Prev 2004; 28: 237243.
  • 41
    Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003; 15;63: 11791182.
  • 42
    Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumour progression in human laryngeal carcinomas. Cancer Res 1994; 54: 48134817.
  • 43
    Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993; 119: 12381243.
  • 44
    Haythem A, Muhyi A. Nasopharyngeal cancer. Hematology/oncology clinics of North America. 1999. p 837847.
  • 45
    Riva C, Lavieille JP, Reyt E, Brambilla E, Lunardi J, Brambilla C. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Eur J Cancer B Oral Oncol 1995; 31: 384391.
  • 46
    Smith DR, Goh HS. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumour suppressor gene. Clin Cancer Res 1996; 2: 10491053.